Sana Biotechnology Presents at Life Sciences Conference

CEO discusses the company's 7-year history and vision for the future of biotechnology.

Mar. 18, 2026 at 8:52am

Got story updates? Submit your updates here. ›

Sana Biotechnology, a 7-year-old biotech company, presented at the Citizens Life Sciences Conference in Miami, Florida. CEO Steven Harr provided an overview of the company's origins and goals, noting that one of the most important transformations over the next couple of decades will be the advancement of biotechnology. Harr cautioned that the company will make forward-looking statements and advised the audience to review Sana's risk factors outlined in its recently filed 10-K report.

Why it matters

Sana Biotechnology is a prominent player in the rapidly evolving biotechnology industry, which is expected to see significant advancements in the coming decades. The company's presentation at a major life sciences conference provides insight into its strategic vision and the potential impact of its work.

The details

Sana Biotechnology was founded about 7 years ago with the goal of driving innovation in the biotechnology field. The company is focused on developing transformative therapies and technologies that could have a profound impact on human health and wellbeing.

  • Sana Biotechnology was founded approximately 7 years ago.
  • The company presented at the Citizens Life Sciences Conference on March 11, 2026.

The players

Sana Biotechnology, Inc.

A 7-year-old biotech company focused on developing transformative therapies and technologies.

Steven Harr

The President, CEO, and Director of Sana Biotechnology, Inc.

Got photos? Submit your photos here. ›

What they’re saying

“I never know exactly who's in the audience or who's listening on the webcast, whether they know the Sana story or not. And so I'd love to start off maybe in 2 to 4 minutes with an overview of Sana before we dive into some specific questions.”

— Steven Harr, President, CEO & Director

“First of all, thank you for having me and the company come down here and enjoy beautiful sunny Miami. And thank you to people here in the audience and to those listening online. You probably know before I get started, we will make forward-looking statements and check out our risk factors in our recently filed 10-K. There, we try to do a very thorough job and help you understand all the things that could go -- or many of the things that could go wrong. I don't think we'll ever capture all of them. The -- we do our best.”

— Steven Harr, President, CEO & Director

What’s next

Sana Biotechnology will continue to develop its transformative biotechnology solutions and provide updates to investors and the public on its progress.

The takeaway

Sana Biotechnology is a promising player in the rapidly evolving biotechnology industry, with a focus on developing innovative therapies and technologies that could have a significant impact on human health. The company's presentation at the Citizens Life Sciences Conference provides a glimpse into its strategic vision and the potential of its work.